Home
About
- About Molecure S.A.
- Our Team
R&D
Patients
Investors & media
Careers
Contact
- Whistleblowers

Metabolomic reprogramming of the tumor microenvironment by dual arginase inhibitor OATD-02 boosts anticancer immunity

About us

Molecure is an innovative biotechnology company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.